Myricx Bio Alternatives & Competitors
12 companies similar to Myricx Bio — Developing a new class of ADCs based on NMT inhibition to treat cancer
Indi Molecular
Indi Molecular is an emerging life sciences company developing synthetic molecules with an...
Culver City, United State...
DEM Biopharma, Inc.
Novel Target for Solid Tumors
Cambridge, United States
Light Chain Bioscience | Novimmune SA
Light Chain Bioscience – A brand of Novimmune SA
Plan-les-ouates, Switzerl...
Vernalis
We develop and apply fragment and structure-based methods to solve problems in drug discov...
Cambridge, United Kingdom
Track all Myricx Bio competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Exelixis
Exelixis works on discovering, developing, and commercializing therapies for the treatment...
Alameda, United States
Ensem Therapeutics
Kinetic Ensemble™ Platform for Precision Medicine
Waltham, United States
Pentixapharm AG
improves the life of patients with malignant diseases through targeted molecular diagnosti...
Wurzburg, Germany
Samsung Biologics
Innovation, passion and an unwavering dedication to find breakthrough solutions in biomedi...
Korea South
NiKang Therapeutics Inc.
Wilmington, United States
Ofichem Group
Family-owned CDMO and pharmaceutical supplier
The Netherlands
Protillion Biosciences
Revolutionary deep tech for the design and development of protein-based drugs
Carlsbad, United States
Tubulis GmbH
Reimagining ADCs.
Germany
About Myricx Bio
Developing a new class of ADCs based on NMT inhibition to treat cancer
Discovery and development of novel ADCs, Preclinical efficacy and safety testing, Clinical team expansion and regulatory affairs
Oncologists, Pharmaceutical companies, Biotechnology partners, Research institutions
Biotech, Antibody Drug Conjugates, ADC Development, N-Myristoyltransferase Inhibitors, NMT Inhibition, Oncology Treatment, Cytotoxic Payload Development, Small Molecule Drug Discovery, Cancer Therapy, Preclinical Efficacy, Drug Development Pipeline, Targeted Cancer Therapy, Novel Therapeutic Modalities, Solid Tumor Antigens
B2B
Licensing, Performance Based, Product Sales
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Myricx Bio and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Myricx Bio on 15 Jun 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.